New Deal
Roger Cohen
Partner at Goodwin Procter
Lawyer
New York
Deal Bio
Clementia Pharmaceuticals
IPSEN
£995m
41 dealmakers
Bellwyck Pharma Services
Pci Pharma Services
value n/a
Immatics Biotechnologies
Arya Sciences Acquisition Corp
£288m
73 dealmakers
Adicet Bio
Restorbio
45 dealmakers
TRINETX
The Carlyle Group
51 dealmakers
Normatec Industries
HYPERICE
42 dealmakers
Specialty Networks
Linden Capital Partners
35 dealmakers
Discovery Health Partners
Multiplan Corp
£113m
30 dealmakers
HUMACYTE
Alpha Healthcare Acquisition
£618m
48 dealmakers
Better Therapeutics
Mountain Crest Acquisition Corp Ii
£135m
44 dealmakers
Lengo Therapeutics
Blueprint Medicines
£348m
57 dealmakers
Senti Biosciences
Dynamics Special Purpose Corporation
£453m
Checkmate Pharmaceuticals
REGENERON
£191m
62 dealmakers
Parata Systems
Becton Dickinson & Company
£1,220m
49 dealmakers
Apollo Intelligence Corporation
Frazier Healthcare Partners
40 dealmakers
Forma Therapeutics
Novo Nordisk
£944m
65 dealmakers
SESAME
Fmz Ventures
£22m
19 dealmakers
Capital Rx
B Capital Group
£86m
PICNICHEALTH
£48m
11 dealmakers
KALEYRA
Tata Communications
£78m
Graphite Bio
Lenz Therapeutics
£181m
92 dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.